Predictive biomarkers of response to immune checkpoint inhibitors in metastatic renal cell carcinoma

被引:0
|
作者
Motoshima, Takanobu
Miura, Yuji
Amami, Toshiki
Kitano, Shigeyasu
Baba, Masaya
Kamba, Tomomi
机构
关键词
D O I
10.1158/1538-7445.AM2023-3308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3308
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Negishi, Takahito
    Nakagawa, Tohru
    Nishiyama, Naotaka
    Kitamura, Hiroshi
    Okajima, Eijiro
    Furubayashi, Nobuki
    Hori, Yoshifumi
    Kuroiwa, Kentarou
    Son, Yuhyon
    Seki, Narihito
    Tomoda, Toshihisa
    Nakamura, Motonobu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (12) : 1430 - 1435
  • [22] Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma
    Rizk, Emanuelle M.
    Seffens, Angelina M.
    Trager, Megan H.
    Moore, Michael R.
    Geskin, Larisa J.
    Gartrell-Corrado, Robyn D.
    Wong, Winston
    Saenger, Yvonne M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (01) : 1 - 11
  • [23] Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma
    Emanuelle M. Rizk
    Angelina M. Seffens
    Megan H. Trager
    Michael R. Moore
    Larisa J. Geskin
    Robyn D. Gartrell-Corrado
    Winston Wong
    Yvonne M. Saenger
    American Journal of Clinical Dermatology, 2020, 21 : 1 - 11
  • [24] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean T.
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [25] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [26] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Checkpoint inhibitors in metastatic papillary renal cell carcinoma
    de Vries-Brilland, M.
    McDermott, D. F.
    Suarez, C.
    Powles, T.
    Gross-Goupil, M.
    Ravaud, A.
    Flippot, R.
    Escudier, B.
    Albiges, L.
    CANCER TREATMENT REVIEWS, 2021, 99
  • [28] Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC)
    Rathi, Nityam
    Stenehjem, David D.
    Agarwal, Neeraj
    Hahn, Andrew W.
    Sirohi, Deepika
    Sharma, Prayushi
    Koh, Mei Yee
    Maughan, Benjamin Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Oliva, M.
    Spreafico, A.
    Taberna, M.
    Alemany, L.
    Coburn, B.
    Mesia, R.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 57 - 67
  • [30] Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Lang, Herve
    Werle, Pierre
    Balssa, Lac
    Geoffrois, Lionnel
    Leblanc, Louis
    Albiges, Laurence
    di Nunno, Vincenzo
    Bensalah, Karim
    Ladoire, Sylvain
    Gravis, Gwenaelle
    Barthelemy, Philippe
    EUROPEAN UROLOGY, 2020, 77 (06) : 761 - 763